Oxidative Stress and Preeclampsia-Associated Prothrombotic State
Open Access
- 16 November 2020
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 9 (11), 1139
- https://doi.org/10.3390/antiox9111139
Abstract
Preeclampsia (PE) is a common obstetric disease characterized by hypertension, proteinuria, and multi-system dysfunction. It endangers both maternal and fetal health. Although hemostasis is critical for preventing bleeding complications during pregnancy, delivery, and post-partum, PE patients often develop a severe prothrombotic state, potentially resulting in life-threatening thrombosis and thromboembolism. The cause of this thrombotic complication is multi-factorial, involving endothelial cells, platelets, adhesive ligands, coagulation, and fibrinolysis. Increasing evidence has shown that hemostatic cells and factors undergo oxidative modifications during the systemic inflammation found in PE patients. However, it is largely unknown how these oxidative modifications of hemostasis contribute to development of the PE-associated prothrombotic state. This knowledge gap has significantly hindered the development of predictive markers, preventive measures, and therapeutic agents to protect women during pregnancy. Here we summarize reports in the literature regarding the effects of oxidative stress and antioxidants on systemic hemostasis, with emphasis on the condition of PE.Keywords
This publication has 173 references indexed in Scilit:
- Nitric Oxide and Carbon Monoxide Production and Metabolism in PreeclampsiaReproductive Sciences, 2012
- Microparticles in Hemostasis and ThrombosisCirculation Research, 2011
- Disulfide bond reduction of von Willebrand factor by ADAMTS‐13Journal of Thrombosis and Haemostasis, 2010
- Review: Reactive oxygen and nitrogen species and functional adaptation of the placentaPlacenta, 2010
- Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13Blood, 2010
- Prothrombin Gene G20210A Mutation and Obstetric ComplicationsObstetrics & Gynecology, 2010
- Coenzyme Q10 supplementation during pregnancy reduces the risk of pre‐eclampsiaInternational Journal of Gynecology & Obstetrics, 2009
- Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditionsJournal of Thrombosis and Haemostasis, 2008
- Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ, 2007
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences of the United States of America, 1993